Alembic Pharma gets USFDA nod for hypertension drug
Alembic Pharmaceuticals has received approval from the US health regulator for Candesartan Cilexetil tablets which is used for the treatment of hyper05-12-2018
05-12-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for Candesartan Cilexetil Tablets USP, 4 mg, 8 mg, and 16 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.05-12-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, this is to inform the exchange that the Company's wholly owned subsidiary, Orit Laboratories LLC, received USFDA Approval for Glycopyrrolate Tablets USP, 1 mg and 2 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.04-12-2018
Board Meeting Intimation for Board Meeting To Consider The Fresh Proposal For Issue Of Non-Convertible Debentures On Private Placement Basis
ALEMBIC PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/12/2018 ,inter alia, to consider and approve Please note that the Board of Directors at their meeting held on 10th September, 2018 had approved the Issue of Unsecured Listed Non-Convertible Debentures (NCDs) of upto Rs. 300 Crores on Private Placement Basis. However, due to sudden and steep increase in the interest rates, the Company did not issue any NCDs....03-12-2018
Alembic Pharma gets USFDA nod for insomnia treatment drug
Alembic Pharmaceuticals has received approval from the US health regulator for Temazepam capsules which is used for the treatment of insomnia.The comp27-11-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for Temazepam Capsules USP 7.5mg, 15mg, 22.5mg and 40mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.27-11-2018
Alembic Pharma gets USFDA nod for pain relief ointment
Alembic Pharmaceuticals' joint venture Aleor Dermaceuticals has received approval from the US health regulator for Xylocaine ointment, used for tempor26-11-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
This is to inform the exchange that the Company's joint venture, Aleor Dermaceuticals Limited, has received United States Food and Drugs Administration (USFDA) Approval for Lidocaine Ointment USP, 5%. Please find enclosed herewith our press release. We request you to kindly take the same on record.26-11-2018
Alembic Pharma: USFDA nod adds strength
Alembic Pharmaceuticals on Tuesday said it has received approval from the US FDA to market Vardenafil Hydrochloride orally disintegrating tablets, use20-11-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for Vardenafil Hydrochloride Orally Disintegrating Tablets, 10 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.20-11-2018